Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

Jefferies lifts Reckitt Benckiser stock PT despite downward revision for 1Q24

EditorIsmeta Mujdragic
Published 03/28/2024, 11:05 AM
Updated 03/28/2024, 11:05 AM

On Thursday, Jefferies updated its outlook on Reckitt Benckiser Group PLC (LSE:LON:RKT) (OTC:RBGLY), raising the price target to £41.00 from the previous £40.00. The firm has retained its Underperform rating on the stock.

The adjustment comes as Jefferies anticipates the company's first-quarter results for 2024, which are set to be released on April 24. The firm's analysts expect Reckitt Benckiser's organic sales growth (OSGe) to decline by 2.8% in the first quarter, which is more pessimistic than the consensus estimate of a 1.2% decline.

The analysts have based their projection on the belief that the Nutrition division will no longer benefit from a competitor's recall, and the Health division will face challenges due to the lapping of a strong cold and flu season. Despite the downward revision in OSGe, Jefferies has slightly increased the price target, citing a £4 billion base case litigation risk, which is lower than the previous £5.4 billion estimate.

According to Jefferies, this higher end of a wide range is likely to be factored into the stock's valuation as investors seek visibility for the second half of 2024.

Reckitt Benckiser, a leading consumer health and hygiene company, is expected to face a more significant contribution to its full-year growth during the second half of the year, as indicated by market consensus. The firm's analysts suggest that the current market expectations for the latter part of the year may be overly optimistic, influencing their cautious stance.

The firm's analysis and price target revision offers a nuanced view of the company's short-term prospects ahead of this key financial update.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

InvestingPro Insights

As Reckitt Benckiser Group PLC (OTC:RBGLY) approaches its first-quarter earnings report, real-time data from InvestingPro provides a deeper financial perspective. The company's market capitalization stands at a robust $40.32 billion, with a price-to-earnings (P/E) ratio of 19.63, which adjusts to a more favorable 14.19 based on the last twelve months as of Q4 2023. This adjustment reflects a valuation that may be more in line with the company's earnings. Additionally, the gross profit margin during the same period was an impressive 59.97%, showcasing the company's ability to maintain profitability.

InvestingPro Tips highlight that despite recent price declines—with a 3-month total return of -19.38%—Reckitt Benckiser has a strong track record of dividend payments, having maintained them for 33 consecutive years, and offers a high dividend yield of 6.4%. These factors could appeal to income-focused investors. Moreover, although short-term obligations exceed liquid assets, analysts predict the company will be profitable this year, which may provide some reassurance regarding its financial health.

For those considering an in-depth analysis, InvestingPro offers additional insights, including 7 more InvestingPro Tips for Reckitt Benckiser, which can be accessed at https://www.investing.com/pro/RBGLY. To enhance your research, use coupon code PRONEWS24 to get an additional 10% off a yearly or biyearly Pro and Pro+ subscription, offering you a comprehensive investment toolkit.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.